THE HIGH-DENSITY LIPOPROTEIN-INDUCED AND APOLIPOPROTEIN A-I-INDUCED MOBILIZATION OF CELLULAR CHOLESTEROL IS IMPAIRED IN FIBROBLASTS FROM TANGIER DISEASE SUBJECTS

被引:83
作者
WALTER, M [1 ]
GERDES, U [1 ]
SEEDORF, U [1 ]
ASSMANN, G [1 ]
机构
[1] UNIV MUNSTER,INST ARTERIOSKLEROSEFORSCH,D-48149 MUNSTER,GERMANY
关键词
D O I
10.1006/bbrc.1994.2742
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tangier disease (also known as familial HDL-deficiency) is characterized by very low high density lipoprotein (HDL) plasma levels, splenomegaly, and massive cholesteryl ester accumulation in the cytoplasm of various cell types. Since this phenotype may in part be caused by a defect in the pathway mediating cholesterol efflux from peripheral cells, we investigated the HDL(3)-mediated mobilization of cholesterol synthesized de novo from [C-14]-mevalonolactone in cultivated fibroblasts from two patients with Tangier disease. Our results indicate that the KDL(3)-induced translocation of [C-14]-cholesterol from intracellular pools to the plasma membrane and its subsequent secretion into the extracellular medium was approximately 50 % less in the cells from the patients than in controls. The same result was also obtained with artificial apolipoprotein A-I-containing phospholipid vesicles. By contrast, no significant difference in HDL(3)-induced cholesterol efflux was observed when plasma membrane was labeled with exogenous [C-14]-cholesterol. We conclude that inefficient cholesterol efflux in Tangier disease is primarily caused by impaired HDL(3)-induced activation of cholesterol translocation from intracellular pools to the plasma membrane. (C) 1994 Academic Press, Inc.
引用
收藏
页码:850 / 856
页数:7
相关论文
共 20 条
  • [1] ISOLATION AND CHARACTERIZATION OF AN ABNORMAL HIGH-DENSITY LIPOPROTEIN IN TANGIER DISEASE
    ASSMANN, G
    HERBERT, PN
    FREDRICKSON, DS
    FORTE, T
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (01) : 242 - 252
  • [2] CHARACTERIZATION OF HIGH-DENSITY LIPOPROTEINS IN PATIENTS HETEROZYGOUS FOR TANGIER DISEASE
    ASSMANN, G
    SIMANTKE, O
    SCHAEFER, HE
    SMOOTZ, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (05) : 1025 - 1035
  • [3] LIPOPROTEIN ABNORMALITY IN TANGIER DISEASE - QUANTITATION OF A APOPROTEINS
    ASSMANN, G
    SMOOTZ, E
    ADLER, K
    CAPURSO, A
    OETTE, K
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1977, 59 (03) : 565 - 575
  • [4] ASSMANN G, 1994, IN PRESS METABOLIC B
  • [5] DIFFERENTIAL ROLE OF APOLIPOPROTEIN-AI-CONTAINING PARTICLES IN CHOLESTEROL EFFLUX FROM ADIPOSE-CELLS
    BARKIA, A
    PUCHOIS, P
    GHALIM, N
    TORPIER, G
    BARBARAS, R
    AILHAUD, G
    FRUCHART, JC
    [J]. ATHEROSCLEROSIS, 1991, 87 (2-3) : 135 - 146
  • [6] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [7] EARLY INCORPORATION OF CELL-DERIVED CHOLESTEROL INTO PRE-BETA-MIGRATING HIGH-DENSITY LIPOPROTEIN
    CASTRO, GR
    FIELDING, CJ
    [J]. BIOCHEMISTRY, 1988, 27 (01) : 25 - 29
  • [8] CHEN CH, 1982, J LIPID RES, V23, P680
  • [9] FOLCH J, 1957, J BIOL CHEM, V226, P497
  • [10] LIPID EXTRACTION OF TISSUES WITH A LOW-TOXICITY SOLVENT
    HARA, A
    RADIN, NS
    [J]. ANALYTICAL BIOCHEMISTRY, 1978, 90 (01) : 420 - 426